Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks

This study has been completed.
Sponsor:
Collaborators:
AstraZeneca
Information provided by (Responsible Party):
Grace McComsey, University Hospital Case Medical Center
ClinicalTrials.gov Identifier:
NCT01218802
First received: October 8, 2010
Last updated: August 14, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
No publications provided by University Hospital Case Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):